SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-20-000299
Filing Date
2020-10-14
Accepted
2020-10-14 08:43:45
Documents
4
Period of Report
2020-10-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngio101220form8k.htm 8-K 217040
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 173857
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 19736
4 GRAPHIC image_001.gif GRAPHIC 4696
  Complete submission text file 0001607062-20-000299.txt   418194
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 (416) 364-2551
NUGENEREX IMMUNO-ONCOLOGY, INC. (Filer) CIK: 0001804585 (see all company filings)

IRS No.: 043208418 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-56153 | Film No.: 201238283
SIC: 2834 Pharmaceutical Preparations